These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23537507)

  • 21. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.
    Hong Y; Li HF; Skeie GO; Romi F; Hao HJ; Zhang X; Gao X; Owe JF; Gilhus NE
    J Neuroimmunol; 2016 Sep; 298():51-7. PubMed ID: 27609275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
    Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
    J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle autoantibodies in myasthenia gravis: beyond diagnosis?
    Meriggioli MN; Sanders DB
    Expert Rev Clin Immunol; 2012 Jul; 8(5):427-38. PubMed ID: 22882218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic use of autoantibodies in myasthenia gravis.
    Leite MI; Waters P; Vincent A
    Autoimmunity; 2010 Aug; 43(5-6):371-9. PubMed ID: 20380582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoantibodies in myasthenia gravis].
    Motomura M; Narita Masuda T
    Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population.
    Chang T; Leite MI; Senanayake S; Gunaratne PS; Gamage R; Riffsy MT; Jacobson LW; Adhikari M; Perera S; Vincent A
    J Neurol Sci; 2014 Aug; 343(1-2):82-7. PubMed ID: 24929651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
    Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
    J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MuSK antibodies, lessons learned from poly- and monoclonality.
    Vergoossen DLE; Augustinus R; Huijbers MG
    J Autoimmun; 2020 Aug; 112():102488. PubMed ID: 32505442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management.
    Lazaridis K; Tzartos SJ
    Front Neurol; 2020; 11():596981. PubMed ID: 33329350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
    Koneczny I; Herbst R
    Cells; 2019 Jul; 8(7):. PubMed ID: 31269763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.